WeWork's IPO papers show the office-space company generated $1.5 billion in revenue in the first half of 2019, but a net loss of about $690 million
WeWork’s parent company unveiled the papers for its initial public offering Wednesday, taking the next step toward the office-space firm’s high-profile debut as soon as September.
The filing gives the most detailed financial picture to date of We Co., which was known as WeWork Cos. until recently. We generated $1.54 billion in revenue in the first six months of 2019 and posted a net loss of $689.7 million. In 2018, the company raked in $1.82 billion in revenue, but it also lost $1.61 billion.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WeWork just dropped its filing to go public, revealing its financials ahead of IPOWeWork released its much-anticipated IPO prospectus, joining a flurry of tech companies going public in 2019.
Consulte Mais informação »
WeWork files for IPOThe Securities and Exchange Commission filing provides the first in-depth look at WeWork's financial results.
Consulte Mais informação »
Saudi Aramco Investor Relations Call Reveals Massive Profits But Fails To Address Key IPO ConcernsSaudi Aramco's financials reveal large dividend paid to Saudi government despite lower profits in 2019
Consulte Mais informação »
All the businesses under The We Company, the $47 billion WeWork owner that could reveal its IPO paperwork any day nowOriginally called WeWork, the We Company rebranded at the start of 2019 in order to make room for spin-off businesses WeLive, WeGrow, and Rise by We.
Consulte Mais informação »
Aramco, Setting Stage for IPO, Bulks Up on Refining With $15 Billion DealSaudi Aramco is buying a stake in Reliance’s energy business, worth some $15 billion including debt, a move that would help match its enormous crude production with refining capacity, as it gears up for its planned IPO.
Consulte Mais informação »
Adaptive Biotechnologies stock tumbles after first earnings report since IPOAdaptive Biotechnologies shares fell by more than 7% in after-hours trading Tuesday after the biotech company posted a wider-than-expected loss in its first earnings report since going public.
Consulte Mais informação »